Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

Biodegradability additives may cause environmental harm: SPC

The SPC takes a formal stance against biodegradability additives for petroleum-based plastics noting a lack sustainable advantages and the potential for environmental harm.

Pw 150158 Spc

The Sustainable Packaging Coalition (SPC) has released a formal position paper against biodegradability additives for petroleum-based plastics, which are marketed as enhancing the sustainability of plastic by rendering the material biodegradable. The SPC has evaluated the use of biodegradability additives for conventional petroleum-based plastics and has found that these additives do not offer any sustainability advantage and they may actually result in more environmental harm.

The position paper lists the following reasons for the stance against these additives:

  • They don’t enable compostability, which is the meaningful indicator of a material’s ability to beneficially return nutrients to the environment.
  • They are designed to compromise the durability of plastic, and the additive manufacturers have not yet demonstrated an absence of adverse effects on recycling.
  • The creation of a “litter friendly” material is a step in the wrong direction, particularly when the material may undergo extensive fragmentation and generation of micro-pollution before any biodegradation occurs.
  • The biodegradation of petroleum-based plastics releases fossil carbon into the atmosphere, creating harmful greenhouse gas emissions.

“We strongly urge companies and government agencies to separate facts from misleading marketing language and help us generate the understanding that plastics are more sustainable without biodegradability additives,” says Adam Gendell, Senior Manager of the Sustainable Packaging Coalition. “We’ve been disappointed by the uptake from brands and manufacturers as well as governments mandating their usage in other countries, and we’re hopeful that our position will help inform better decisions.”

This formal position coincides with the recent Federal Trade Commission’s ongoing crackdown on false and misleading environmental claims, including five enforcement actions that specifically address biodegradable plastic claims. While the FTC action centers on the efficacy of the additives and their ability to work as advertised, the SPC’s stance is centered on the idea that the additives do not provide environmental benefits even if they do work as advertised.

“We feel strongly that the most ideal end-of-life scenario for petroleum-based plastics is recycling,” says Gendell. “There are ample opportunities for the sustainable usage of petroleum-based plastics, and we need solutions that help realize those opportunities. Unfortunately, biodegradability additives are not one of them.”

The full position paper is available for download. 

Conveying Innovations Report
Editors report on distinguishing characteristics that define each new product and collected video demonstrating the equipment or materials as displayed at the show. This topical report, winnowed from nearly 300 PACK EXPO collective booth visits, represents a categorized, organized account of individual items that were selected based on whether they were deemed to be both new, and truly innovative, based on decades of combined editorial experience in experiencing and evaluating PACK EXPO products.
Take me there
Conveying Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report